These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4757640)

  • 1. [Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].
    Goldstein C; Sumoza A; De Bosch N; De Sanz N
    Sangre (Barc); 1973; 18(3):313-21. PubMed ID: 4757640
    [No Abstract]   [Full Text] [Related]  

  • 2. A coagulopathy of the owl monkey (Aotus trivirgatus) associated with high antithrombin III activity.
    Loeb WF; Cicmanec JL; Wickum M
    Lab Anim Sci; 1976 Dec; 26(6 Pt 2):1084-7. PubMed ID: 828226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in antithrombin 3 levels following cessation of anticoagulant therapy.
    Refvem O; Fagerhol MK; Abildgaard U
    Acta Med Scand; 1973 Apr; 193(4):307-9. PubMed ID: 4197871
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3].
    Fujimaki M; Nagasawa H
    Nihon Rinsho; 1974 May; 32(5):942-7. PubMed ID: 4211348
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulant treatment during abdominal surgery in a case of antithrombin 3 deficiency.
    Egberg N; Thulin L
    Acta Chir Scand; 1973; 139(6):577-8. PubMed ID: 4127705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Method of determining total antithrombin activity, antithrombins II, 3 and IV].
    Babich VP; Byshevskii ASh
    Lab Delo; 1972; 8():467-70. PubMed ID: 4124339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypercalcemia and antithrombin activity in a case of IgA myeloma].
    Baele G; Lameire N
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1444-50. PubMed ID: 5069831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of blood coagulation factors in vivo due to triiodized x-ray contrast media. (Preliminary report)].
    Maurer HJ; Brüster H
    Rontgenblatter; 1972 Mar; 25(3):116-20. PubMed ID: 5048540
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of new methods for studies in the area of blood coagulation. 3. Gel diffusion test for quantitative determination of total antithrombin capacity of plasma].
    Doleschel W
    Wien Med Wochenschr; 1972 Oct; 122(42):601-6. PubMed ID: 4628200
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasmatic antithrombin activity in multiple myeloma].
    Nenci GG; Notaristefano A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1389-91. PubMed ID: 5398278
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of antithrombin III activity in hypercoagulability].
    von Kaulla E; von Kaulla KN
    Dtsch Med Wochenschr; 1977 Apr; 102(13):496. PubMed ID: 844430
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin 3 deficiency in maturity onset diabetes mellitus and atherosclerosis.
    Banerjee RN; Sahni AL; Kumar V; Arya M
    Thromb Diath Haemorrh; 1974 May; 31(2):339-45. PubMed ID: 4850610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Thrombin and antithrombin activity" in patients with acute myocardial infarct and in subjects treated by anticoagulant therapy].
    Jean G; Praga C; Lambertenghi G; Cortellaro M
    Folia Cardiol; 1965; 24(5):282-90. PubMed ID: 5898888
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of circulating anticoagulant analysis in blood coagulo-fibrinolytic analysis].
    Watanabe K
    Nihon Rinsho; 1989 Dec; 48 Suppl():938-41. PubMed ID: 2622033
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal aortic thrombosis. A possible clinical manifestation of congenital antithrombin 3 deficiency.
    Bjarke B; Herin P; Blombäck M
    Acta Paediatr Scand; 1974 Mar; 63(2):297-301. PubMed ID: 4820598
    [No Abstract]   [Full Text] [Related]  

  • 17. "Limited proteolysis," a new bleeding syndrome with circulating fibrinogen fragments.
    Oldham FB; Warner D; Kalmaz E; Hampton JW
    J Lab Clin Med; 1971 Nov; 78(5):846. PubMed ID: 5128897
    [No Abstract]   [Full Text] [Related]  

  • 18. Detecting antithrombin deficiency may be a difficult task--more than one test is necessary.
    Kristensen SR; Rasmussen B; Pedersen S; Bathum L
    J Thromb Haemost; 2007 Mar; 5(3):617-8. PubMed ID: 17229050
    [No Abstract]   [Full Text] [Related]  

  • 19. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
    Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lupus anticoagulant: report of a case.
    Barber K; Freed N; Proebstle P; Biondi R
    J Am Osteopath Assoc; 1983 May; 82(9):669-73. PubMed ID: 6408034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.